ABSTRACT
Introduction:
Osteoporotic hip fractures have become a current major problem with increasing life expectancy. In order to decrease morbidity and mortality, preventive measures and early health care interventions are very important. The aim of this study is to present the epidemiologic profile of the geriatric proximal femur fractures and to specify and determine the factors that effect the patient outcomes.
Materials and Methods:
The patients aged over 65 with hip fractures have been included in this retrospective, observational study. The factors regarding demographic features, fracture types, treatment outcomes, time to surgery, comorbidities, red blood cell transfusion requirement, intensive care unit admission, the length of anesthesia and the operation have been investigated.
Results:
Eight hundred sixty-four (571 female, 293 male) have been included in the study. The average age of the patients was 81,6. The most frequent comorbidity was hypertension (464 patients, 53%), 829 patients were diagnosed as osteoporosis according to Singh index, sixty-six patients (7,6%) were died during the 1 month period. Whereas the one year mortality rate was 28,5% (246 patient), the overall mortality rate was 38%. Age, collum femoris fracture, accompanying pulmonary diseases and central nervous system diseases, delayed time to surgery and intensive care admission increase 1-year mortality.
Conclusion:
With an increased proportion of elderly individuals in the general population, the number of elderly hip fracture patients continue to increase. In order to minimize complications, geriatric hip fracture patients should be operated on as soon as possible, and a multidisciplinary treatment process should be planned precisely.
Keywords:
Elderly, Hip fracture, MortalityVOLUME
,
ISSUE
Correspondence
Received
Accepted
Published
Suggested Citation
DOI
License
ADVANCE KNOWLEDGE. SHARE YOUR RESEARCH. PUBLISH WITH PURPOSE—FREE OF CHARGE
Yeditepe Journal of Health Sciences is an international, open-access journal in health sciences with double-blind peer review and no publication fees.